Lilly In Advanced Talks To Acquire Kelonia Therapeutics For More Than $2 Bln : Report
AAPL
TSLA
AMZN
META
AMD
NVDA
PEP
COST
ADBE
GOOG
AMGN
HON
INTC
INTU
NFLX
ADP
SBUX
MRNA
AAPL
TSLA
AMZN
META
AMD
NVDA
PEP
COST
ADBE
GOOG
AMGN
HON
INTC
INTU
NFLX
ADP
SBUX
MRNA
AAPL
TSLA
AMZN
META
AMD
NVDA
PEP
COST
ADBE
GOOG
AMGN
HON
INTC
INTU
NFLX
ADP
SBUX
MRNA
Markets
LLY
Lilly In Advanced Talks To Acquire Kelonia Therapeutics For More Than $2 Bln : Report
April 19, 2026 — 11:32 pm EDT
Written by
RTTNews.com for
RTTNews->
-
-
-
-
-
(RTTNews) - Eli Lilly (LLY) is in advanced talks to acquire Kelonia Therapeutics for more than $2 billion, according to the Wall Street Journal, citing people familiar with the matter. A deal could be announced as soon as Monday, though the talks may still fall apart. The price may also include additional milestone-based payments if Kelonia achieves certain targets, the report said.
Kelonia Therapeutics is a private biotechnology company based in Cambridge, Massachusetts.
LLY closed at $927.03, rising $23.04 or 2.55% as of April 17. In overnight trading at 8:46:55 PM EDT, the stock slipped to $921.50, down $5.53 or 0.60%.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Tags
Markets
RTTNews
Founded in the late 1990s by Andrew Mariathasan in New York, with the goal of covering Wall Street for a new generation of investors, RTTNews has expanded steadily over the years to become a trusted provider of content for a wide array of subjects across several platforms. RTT's Financial Newswire is relied upon by some of the world's largest financial institutions, including banks, brokerages, trading platforms and financial exchanges.
More articles by this source->
Stocks mentioned
LLY
More Related Articles
This data feed is not available at this time.
Data is currently not available
-
•
Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.